📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Preventing cognitive decline and dementia from cerebral small vessel disease: The LACI-1 Trial. Protocol and statistical analysis plan of a phase IIa dose escalation trial testing tolerability, safety and effect on intermediary endpoints of isosorbide mononitrate and cilostazol, separately and in combination. (2018)

First Author: Blair GW
Attributed to:  Centre for Cognitive Ageing & Cognitive Epidemiology funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1177/1747493017731947

PubMed Identifier: 28906205

Publication URI: http://europepmc.org/abstract/MED/28906205

Type: Journal Article/Review

Volume: 13

Parent Publication: International journal of stroke : official journal of the International Stroke Society

Issue: 5

ISSN: 1747-4930